Comparative Pharmacology
Head-to-head clinical analysis: CHRONULAC versus PEG LYTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHRONULAC versus PEG LYTE.
CHRONULAC vs PEG-LYTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is hydrolyzed by colonic bacteria to form low molecular weight acids (mainly lactic and acetic acid), which osmotically draw water into the colon, softening stools and increasing stool frequency. Additionally, lactulose decreases colonic pH, which traps ammonia (NH3) as ammonium (NH4+), reducing serum ammonia levels.
PEG-LYTE is an osmotic laxative that induces diarrhea by retaining water in the colon through the non-absorbable polyethylene glycol (PEG) and electrolytes, which prevent dehydration and electrolyte imbalance during bowel cleansing.
10-30 mL orally once daily to twice daily; for acute constipation, 20-30 mL initially; for hepatic encephalopathy, 30-60 mL every 1-2 hours to achieve 2-3 soft stools daily.
4 liters orally as a single dose or in divided doses for colonoscopy preparation.
None Documented
None Documented
Terminal elimination half-life approximately 1.5-2.5 hours in adults with normal renal function; may be prolonged to 4-8 hours in patients with renal impairment.
Not applicable; PEG-3350 is minimally absorbed (<0.06%), thus systemic half-life is not clinically relevant. Local gut transit time ~1-2 hours.
Primarily renal (as unchanged drug and metabolites): ~40-50% of dose excreted in urine within 24 hours; biliary/fecal elimination accounts for the remainder, with approximately 2-5% recovered in feces as parent compound.
Primarily fecal (98-99%) as unchanged polyethylene glycol (PEG) 3350; negligible renal excretion (<0.2%). Electrolytes (sodium, potassium, bicarbonate) are partially absorbed and excreted renally.
Category C
Category C
Osmotic Laxative
Osmotic Laxative